Effect of methylphenidate with and without pyridoxine on attention deficit hyperactivity disorder in children

Effect of methylphenidate with and without pyridoxine on attention deficit hyperactivity disorder in children: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N218

Enrollment

Registered

2018-05-04

Start date

2017-04-09

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit hyperactivity disorder. Attention-deficit hyperactivity disorders

Interventions

Intervention 1: Intervention group: Tablet methylphenidate 5 mg to 40 mg for 2 weeks and tablet pyridoxine40 mg every 12 hours for 2 weeks. Intervention 2: Control group: Tablet methylphenidate 5 mg t

Eligibility

Sex/Gender

All

Age

5 Years to 12 Years

Inclusion criteria

Inclusion criteria: Age of 5 to 12 years Attention deficit hyperactivity disorder

Exclusion criteria

Exclusion criteria: Convulsion disorders Using multivitamin Contraindication for methylphenidate

Design outcomes

Primary

Measure	Time frame
Improvement of clinical signs and symptoms. Timepoint: Two weeks after intervention. Method of measurement: Through physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shahin Seifodin

Hamedan University of Medical Sciences

Drseifodin@yahoo.com+98 81 3364 0030

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026